Image

Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.

Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

  1. Assess differences in flow patterns in the fetal cerebral blood vessels within 24 hours before delivery between fetuses with a normal vs. adverse perinatal outcome.
  2. Explore maternal and/or fetal characteristics that might influence technical feasibility of doppler sonography of the fetal cerebral blood vessels in early labor at term.
  3. Assess reliability of the technique by measuring intra- and inter-observer variation in a subset of participants.

Eligibility

Inclusion Criteria:

  • Singleton pregnancy.
  • Term gestation (37-42 weeks).
  • Fetus in cephalic presentation.
  • No known fetal chromosomal or (severe) congenital anomaly.
  • Normally grown fetus (ultrasound scan demonstrating normal fetal growth between 30-37 weeks of gestation, defined as an estimated fetal weight/abdominal circumference > 10th centile or crossing <2 quartiles compared to earlier growth ultrasound).
  • Absence of pre-existing doppler or amniotic fluid abnormalities.
  • Normal fetal heart rate tracing / CTG (excluding pre-existing hypoxia).
  • Admission in early spontaneous labor or induction of labor with expected delivery < 24 hours.
  • Maternal age >= 18 years
  • Willing to give written informed consent.

Exclusion Criteria:

  • Advanced labor (> 4cm of cervical dilatation) at the time of admission on the labor ward.
  • Severe pre-existing chronic maternal medical condition or poor obstetric history/antenatal complications associated with increased risk of adverse perinatal outcome (non-exhaustive e.g.: uncontrolled chronic hypertension, severe pre-eclampsia, uncontrolled (gestational) diabetes, maternal sepsis, major antepartum haemorrhage, intra-uterine infection, prolonged rupture of membranes > 18 hours, etc.).
  • Intra-uterine fetal demise / death.
  • Prelabour rupture of membranes with meconium-stained amniotic fluid.
  • Patients not fulfilling all the inclusion criteria or refusing to give written informed consent.

Study details
    Ultrasonography
    Doppler
    Obstetric Labor Complications

NCT05599178

Universitaire Ziekenhuizen KU Leuven

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.